EBS - Emergent Biosolutions - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

EBS is currently covered by 1 analysts with an average price target of $12. This is a potential upside of $4.64 (47.42%) from yesterday's end of day stock price of $8.14.

Emergent Biosolutions's activity chart (see below) currently has 20 price targets and 33 ratings on display. The stock rating distribution of EBS is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 67.83% with an average time for these price targets to be met of 152.43 days.

Highest price target for EBS is $12, Lowest price target is $12, average price target is $12.

Most recent stock forecast was given by from HC WAINWRIGHT on 09-Mar-2026. First documented stock forecast 27-Sep-2017.

Currently out of the existing stock ratings of EBS, 6 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 30-Dec-2024

$12

$3.47 (40.68%)

$15

4 months ago
(09-Mar-2026)

0/12 (0%)

$3.65 (43.71%)

Buy Since 11-Apr-2024

$12

$3.47 (40.68%)

$8

1 years 8 months 2 days ago
(07-Nov-2024)

7/11 (63.64%)

$1 (9.09%)

72

Sell Since 20-Nov-2023

$9

2 years 7 months 19 days ago
(20-Nov-2023)

2/2 (100%)

$0.88 (10.84%)

7

Hold Since 12-Sep-2022

$15

$7.04 (88.44%)

$29

3 years 1 months 20 days ago
(19-May-2023)

4/8 (50%)

$6.83 (83.60%)

86

Buy Since 30-Apr-2021

$55

$47.04 (590.95%)

$65

3 years 8 months ago
(09-Nov-2022)

5/11 (45.45%)

$42.15 (328.02%)

140

Show more analysts

Please expand the browser size to see the chart

What is EBS (Emergent Biosolutions) average time for price targets to be met?

On average it took 152.43 days on average for the stock forecasts to be realized with a an average price target met ratio 67.83

Which analyst has the current highest performing score on EBS (Emergent Biosolutions) with a proven track record?

WILLIAM WALLACE

Which analyst has the most public recommendations on EBS (Emergent Biosolutions)?

William Wallace has 5 price targets and 6 ratings on EBS

Which analyst is the currently most bullish on EBS (Emergent Biosolutions)?

Dana Flanders with highest potential upside - $93.04

Which analyst is the currently most reserved on EBS (Emergent Biosolutions)?

Brandon Folkes with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?